10x Genomics, Inc. cotiza a 71.79 USD y tiene una capitalización bursátil de $9.4B. En los últimos 12 meses ha facturado $617M con un margen de flujo de caja libre del 20.2%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of indiv…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.03 | $0.07 | $0.07 |
| Estimado | $-0.02 | $-0.02 | $-0.06 | $-0.04 |
| Sorpresa | — | +250.0% | +216.7% | +275.0% |
| Métrica | TXG | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 69.0% | 57.0% | +12.0% |
| Operating Margin | -9.5% | -38.6% | +29.1% |
| Net Margin | -6.8% | -33.6% | +26.8% |
| FCF Margin | 20.2% | -13.9% | +34.1% |
| ROE | -5.5% | -40.4% | +34.9% |
| ROA | -4.2% | -32.0% | +27.8% |
| Current Ratio | 4.46 | 2.84 | +1.62 |
| Debt / Equity | — | 0.28 | — |